Sponsor:
Rare Thyroid Therapeutics International AB
Code:
NCT05579327
Conditions
Monocarboxylate Transporter 8 Deficiency
Allan-Herndon-Dudley Syndrome
Eligibility Criteria
Sex: Male
Age: 4+
Healthy Volunteers: Not accepted
Interventions
Tiratricol
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-25. This information was provided to ClinicalTrials.gov by Rare Thyroid Therapeutics International AB on 2025-01-13.